Molecular Templates, Inc.Molecular Templates, Inc.Molecular Templates, Inc.

Molecular Templates, Inc.

No trades
See on Supercharts
Market capitalization
‪8.49 M‬USD
−1.56USD
‪−8.12 M‬USD
‪57.31 M‬USD
‪2.95 M‬
Beta (1Y)
−0.38

About Molecular Templates, Inc.

CEO
Eric E. Poma
Website
Headquarters
Austin
Employees (FY)
62
Founded
2000
ISIN
US6085502085
FIGI
BBG000NRVRG3
Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2001 and is headquartered in Austin, TX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MTEM is 1.49 USD — it has decreased by 6.01% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Molecular Templates, Inc. stocks are traded under the ticker MTEM.
Molecular Templates, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
MTEM stock is 8.97% volatile and has beta coefficient of −0.38. Check out the list of the most volatile stocks — is Molecular Templates, Inc. there?
One year price forecast for Molecular Templates, Inc. has a max estimate of 18.00 USD and a min estimate of 18.00 USD.
MTEM earnings for the last quarter are −0.82 USD whereas the estimation was −1.95 USD which accounts for 57.95% surprise. Estimated earnings for the next quarter are −0.97 USD. See more details about Molecular Templates, Inc. earnings.
Molecular Templates, Inc. revenue for the last quarter amounts to ‪6.80 M‬ USD despite the estimated figure of ‪2.47 M‬ USD. In the next quarter revenue is expected to reach ‪7.78 M‬ USD.
Yes, you can track Molecular Templates, Inc. financials in yearly and quarterly reports right on TradingView.
MTEM stock has fallen by 19.73% compared to the previous week, the month change is a 33.41% fall, over the last year Molecular Templates, Inc. has showed a 79.08% decrease.
MTEM net income for the last quarter is ‪−3.95 M‬ USD, while the quarter before that showed ‪−4.15 M‬ USD of net income which accounts for 4.94% change. Track more Molecular Templates, Inc. financial stats to get the full picture.
Today Molecular Templates, Inc. has the market capitalization of ‪8.49 M‬, it has increased by 4.21% over the last week.
No, MTEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MTEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Molecular Templates, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MTEM reached its all-time high on Apr 17, 2006 with the price of 16803.48 USD, and its all-time low was 1.68 USD and was reached on Mar 20, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 62.00 employees. See our rating of the largest employees — is Molecular Templates, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Molecular Templates, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Molecular Templates, Inc. stock shows the strong sell signal. See more of Molecular Templates, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Molecular Templates, Inc. future price: according to them, MTEM price has a max estimate of 18.00 USD and a min estimate of 18.00 USD. Read a more detailed Molecular Templates, Inc. forecast: see what analysts think of Molecular Templates, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Molecular Templates, Inc. EBITDA is ‪−3.68 M‬ USD, and current EBITDA margin is −6.20%. See more stats in Molecular Templates, Inc. financial statements.